Shuai He

502 total citations
17 papers, 294 citations indexed

About

Shuai He is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Shuai He has authored 17 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Shuai He's work include RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (3 papers). Shuai He is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (3 papers). Shuai He collaborates with scholars based in China, United States and Australia. Shuai He's co-authors include Aimin Ji, Bohong Cen, Wenjie Liao, Zhuomin Wu, Yixin Qin, Xialin Zuo, Na Yu, Qian Xu, Ping Wu and Zhen Wang and has published in prestigious journals such as Nature Communications, International Journal of Biological Macromolecules and Bioconjugate Chemistry.

In The Last Decade

Shuai He

17 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuai He China 8 206 162 27 24 22 17 294
Allison L. Isola United States 6 238 1.2× 119 0.7× 44 1.6× 27 1.1× 18 0.8× 8 325
Francesca Maria Orlandella Italy 13 188 0.9× 141 0.9× 29 1.1× 19 0.8× 29 1.3× 26 317
Shuai Meng China 7 197 1.0× 112 0.7× 12 0.4× 31 1.3× 16 0.7× 18 321
Hyun‐Ju An South Korea 10 203 1.0× 104 0.6× 31 1.1× 9 0.4× 18 0.8× 34 318
Fushuang Zheng China 9 255 1.2× 219 1.4× 11 0.4× 11 0.5× 26 1.2× 18 309
Tan Wu China 8 250 1.2× 202 1.2× 10 0.4× 23 1.0× 27 1.2× 23 333
Xinyan Zhou China 9 273 1.3× 215 1.3× 31 1.1× 16 0.7× 20 0.9× 24 367
Changlong Bi China 10 127 0.6× 71 0.4× 22 0.8× 6 0.3× 23 1.0× 25 240

Countries citing papers authored by Shuai He

Since Specialization
Citations

This map shows the geographic impact of Shuai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai He more than expected).

Fields of papers citing papers by Shuai He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai He. The network helps show where Shuai He may publish in the future.

Co-authorship network of co-authors of Shuai He

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai He. A scholar is included among the top collaborators of Shuai He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai He. Shuai He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cen, Bohong, et al.. (2025). Single-cell and spatial analyses reveal the effect of VSIG4+S100A10+TAMs on the immunosuppression of glioblastoma and anti-PD-1 immunotherapy. International Journal of Biological Macromolecules. 308(Pt 3). 142415–142415. 1 indexed citations
2.
He, Shuai, Tao Zhang, Wei Song, & Hongbin Yu. (2025). Feature Bank-Guided Reconstruction for Anomaly Detection. IEEE Signal Processing Letters. 32. 1480–1484. 2 indexed citations
3.
Shen, Yanting, Xiaoling Pan, Jiaqi Li, et al.. (2025). Noncanonical function of Pannexin1 promotes cellular senescence and renal fibrosis post-acute kidney injury. Nature Communications. 16(1). 7699–7699. 1 indexed citations
4.
Chen, Haowei, Xiaorui Shi, Song Xue, et al.. (2024). RNA N6-methyladenosine modification in arthritis: New insights into pathogenesis. Modern Rheumatology. 35(2). 203–214. 1 indexed citations
5.
Chen, Junxiao, et al.. (2024). A pH-Sensitive cRGD-PEG-siRNA Conjugated Compound Targeting Glioblastoma. Bioconjugate Chemistry. 35(11). 1732–1743. 1 indexed citations
6.
7.
Cen, Bohong, Guoxian Li, Yuanyi Wei, et al.. (2021). A bivalent cyclic RGD–siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Delivery. 28(1). 1432–1442. 10 indexed citations
8.
Cen, Bohong, Wenhua Huang, Zheng Chen, et al.. (2021). [Development and functional validation of a nano-delivery system of miR-16/polypeptide targeting ovarian cancer cells].. PubMed. 41(5). 736–746. 2 indexed citations
9.
Wang, Peng, et al.. (2020). SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas. Cancer Cell International. 20(1). 573–573. 13 indexed citations
10.
Cen, Bohong, Wenjie Liao, Zhen Wang, et al.. (2018). Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway. Molecular Therapy — Nucleic Acids. 11. 300–311. 6 indexed citations
11.
Wang, Peng, Jingjing Zhang, Zhen Wang, et al.. (2018). LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway. APOPTOSIS. 23(11-12). 651–666. 29 indexed citations
12.
Cen, Bohong, Yuanyi Wei, Wen Huang, et al.. (2018). An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 13. 220–232. 33 indexed citations
13.
He, Shuai, Bohong Cen, Zhen Wang, et al.. (2017). A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Delivery. 24(1). 471–481. 46 indexed citations
14.
Wu, Zhuomin, Ping Wu, Xialin Zuo, et al.. (2016). LncRNA-N1LR Enhances Neuroprotection Against Ischemic Stroke Probably by Inhibiting p53 Phosphorylation. Molecular Neurobiology. 54(10). 7670–7685. 115 indexed citations
15.
He, Shuai, et al.. (2014). Levofloxacin and proton pump inhibitor‐based triple therapy versus standard triple first‐line therapy for Helicobacter pylori eradication. Pharmacoepidemiology and Drug Safety. 23(5). 443–455. 15 indexed citations
16.
17.
Chen, Lijing, et al.. (2011). [Study on the toxic reaction induced by single dose of qingkailing injection].. PubMed. 34(2). 254–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allison L. Isola Breakdown of academic impact, for papers by Francesca Maria Orlandella Breakdown of academic impact, for papers by Shuai Meng Breakdown of academic impact, for papers by Hyun‐Ju An Breakdown of academic impact, for papers by Fushuang Zheng Breakdown of academic impact, for papers by Tan Wu Breakdown of academic impact, for papers by Xinyan Zhou Breakdown of academic impact, for papers by Changlong Bi
Rankless by CCL
2026